Featured Content

Major Depressive Disorder
FDA Approves New Indication for Esketamine Nasal Spray
The US Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for esketamine (Spravato) CIII nasal spray.
General Psychiatry
Dr. Charles Raison on the Link Between Inflammation and Response to Psychotherapy
Psych Congress cochair Charles Raison, MD, a leading researcher in the field of immune-brain interactions, explains how increased inflammation may affect response to psychotherapy.
Child & Adolescent Psychiatry
Minimizing the Negative Impact of the Pandemic on Children and Adolescents
Psych Congress Steering Committee member Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, discusses how families can minimize the negative impact of the COVID-19 pandemic on children and adolescents.
General Psychiatry
See Full Coverage of the National Conference on Addiction Disorders
The 2020 National Conference on Addiction Disorders (NCAD) for addiction, behavioral, and mental health professionals took place July 30, 2020, through August 2, 2020.
Anxiety Disorders
COVID-19 Acceleration Induced Moderate to Severe Anxiety in Emergency Physicians
During the acceleration phase of the COVID-19 pandemic, emergency medicine physicians in 7 US cities experienced moderate to severe levels of anxiety at work and at home, regardless of the intensity of the local surge.

Blogs

Taking Stock of COVID-Fueled Trends That Are Shaping Behavioral Healthcare
State and County Budget Shortfalls to Reach Almost $650 Billion
New Grand Challenges Initiative Aims to Eradicate Racism

Meetings & Publications

Back to Top